Leveraging collaboration in molecular pathology and skin cancer diagnostics

Leveraging collaboration in molecular pathology and skin cancer diagnostics

April 19, 2016

Trajan Scientific and Medical (Trajan) and the University of Melbourne have embarked on an investigative collaboration today in the fields of molecular pathology and skin cancer diagnostics.

Molecular testing techniques can be used to pursue more accurate cancer screening and disease diagnosis.

Trajan’s emerging tools in micro sampling, sample preparation and mass spectrometry interfaces have generated strong interest in these healthcare applications.

Eight Master of Biotechnology students from the University’s Faculty of Science will be undertaking two industry projects in these areas, with guidance from Trajan mentors Mr Paul Romeo, General Manager, Australia and New Zealand, and Mr Stephen Tomisich, Chief Executive Officer.

"We look forward to fresh insights from the teams, which will help shape Trajan’s roadmap for diagnostic technologies.” said Mr Tomisich.

Academic and industry partnerships are key to Trajan’s collaborative model for innovation, accelerating delivery of scientific and medical solutions to the market that will make a positive impact on human wellbeing.


Photo (L-R): The University of Melbourne student teams at Trajan Global Headquarters in Melbourne, Australia. Paul Romeo (General Manager, Australia and New Zealand, Trajan), Keerthi Kalyan Kothapally, Seumas Shu Men Teh, Angela Tomisich (General Manager, Microscopy Products, Trajan), Robert Lyon (Head of Corporate Development, Trajan), Elpis Barons (General Manager, Accelerator Group, Trajan), Fiona Simpson (Careers and Industry Consultant, The University of Melbourne), Dr Andrew Gooley (Chief Scientific Officer, Trajan), Benjamin Nicholas Le Couteur, Belinda Bich Thuy Thieu Quang, Yanling Wu, Kairui Li, Jie Dong, Jingran Zhang, Rhonda Gailey (Assistant Manager, Corporate Development, Trajan), Dr Matthew Digby (Subject Coordinator, The University of Melbourne), Stephen Tomisich (Chief Executive Officer, Trajan).

More information
Research
The University of Melbourne




Also in News

Trajan Scientific and Medical continues its focus on Microsampling
Trajan Scientific and Medical continues its focus on Microsampling

April 20, 2022

Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland to develop a skin microbiopsy device which takes tissue samples smaller than 0.5mm in diameter.  It can be used to collect biopsies for skin conditions, including skin cancers.

Read More

Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit
Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit

February 16, 2022

Cathy Cordova has been appointed the General Manager of the consolidated Microsampling Business Unit for Trajan Scientific and Medical.

Read More

Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.
Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.

January 27, 2022

 Dr Xumei Gao (Bryan) a Postdoctoral Researcher from the ARC Training Centre for Personalized Therapeutics Technologies at the University of Melbourne, has been awarded a REDI fellowship to partner with Trajan.

Read More